Hotelbuchung
Hotel Registration
Grußwort
Welcome address
Beteiligte Gesellschaften
Societies involved
DOG Information
DOG Information
Eröffnung des Kongresses
Opening Ceremony
Preise
Awards
Ablauf der Tagung 2003
General overview of congress
Lageplan der Räumlichkeiten
Map of Congress Center
Wissenschaftliche Themen
Scientific topics
Symposien
Symposia
Wissenschaftliches Programm
Scientific program
Posterpräsentationen
Poster Presentation
Kurse
Courses
Begleitende Veranstaltungen
Accompanying program
Arbeitssitzungen
Working sessions
Rahmenprogramm
Social program
Allgemeine Informationen
General Information
Autorenindex
Index of Authors
Industrieaussteller
Commercial exhibitors
Sponsoren
Sponsors
Impressum
DOG Homepage
Abstract
Abstract
Surgical Treatment of Vasoproliferative Tumors in Coats Disease
Feudner E., Gelisken F., Besch D., Bartz-Schmidt K. U.
Department of Ophthalmology I, University of Tuebingen
Purpose: Advanced Coats disease may show massive exsudation leading to intra- and subretinal lipid deposition and exsudative retinal detachment. A rare complication in Coats disease is the development of a secondary vasoproliferative tumor. We report on the surgical procedure and results in two patients with exsudative retinal detachment and a vasoproliferative tumor secondary to Coats disease.
Method: We report on two male patients (aged 9 and 30 years) who were first seen 2001 and 2002 with unilateral progressive loss of visual acuity. Visual acuity was 5/125 and 5/100 respectively. Advanced Coats disease with massive intra- and subretinal exsudation, exsudative retinal detachment and a secondary vasoproliferative tumor in the inferior quadrant was diagnosed in both patients. Initial treatment consisted of cryotherapy and laser photocoagulation. In one patient visual acuity transiently increased to 20/200 but decreased again with progression of the retinal detachment. In the other patient visual acuity decreased further to counting fingers due to increasing involvement of the macula by subretinal lipid exsudation. Due to progression of the disease and subsequent decrease of visual acuity vitreo-retinal surgery was performed five and six months after the initial presentation respectively. Surgical treatment included pars plana vitrectomy, retinectomy, endoresection of the vasoproliferative tumor,